The novel kinase inhibitor ponatinib is an effective anti-angiogenic agent against neuroblastoma.

about

The novel kinase inhibitor ponatinib is an effective anti-angiogenic agent against neuroblastoma.

Item

http://www.wikidata.org/entity/Q46644093

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

The novel kinase inhibitor pon ...... c agent against neuroblastoma.

@en

The novel kinase inhibitor pon ...... c agent against neuroblastoma.

@nl

type

Item

label

The novel kinase inhibitor pon ...... c agent against neuroblastoma.

@en

The novel kinase inhibitor pon ...... c agent against neuroblastoma.

@nl

prefLabel

The novel kinase inhibitor pon ...... c agent against neuroblastoma.

@en

The novel kinase inhibitor pon ...... c agent against neuroblastoma.

@nl

P1476

The novel kinase inhibitor pon ...... c agent against neuroblastoma.

@en

P2093

Kalyani Patel

http://www.w3.org/2001/XMLSchema#string

Linna Zhang

http://www.w3.org/2001/XMLSchema#string

Michael Du

http://www.w3.org/2001/XMLSchema#string

Peter E Zage

http://www.w3.org/2001/XMLSchema#string

Sarah B Whittle

http://www.w3.org/2001/XMLSchema#string

Sarah E Woodfield

http://www.w3.org/2001/XMLSchema#string

Valeria Smith

http://www.w3.org/2001/XMLSchema#string

P2860

AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance

Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study

Ponatinib in refractory Philadelphia chromosome-positive leukemias.

FGFR1 mRNA and protein expression, not gene copy number, predict FGFR TKI sensitivity across all lung cancer histologies.

Ponatinib inhibits polyclonal drug-resistant KIT oncoproteins and shows therapeutic potential in heavily pretreated gastrointestinal stromal tumor (GIST) patients.

The angiogenesis inhibitor TNP-470 reduces the growth rate of human neuroblastoma in nude rats.

Identification of Ponatinib as a potent inhibitor of growth, migration, and activation of neoplastic eosinophils carrying FIP1L1-PDGFRA

Sunitinib suppress neuroblastoma growth through degradation of MYCN and inhibition of angiogenesis

Clinical and biologic features predictive of survival after relapse of neuroblastoma: a report from the International Neuroblastoma Risk Group project

Advances in Risk Classification and Treatment Strategies for Neuroblastoma.

P2888

s10637-016-0387-y

P304

685-692

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10637-016-0387-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27586230

http://www.w3.org/2001/XMLSchema#string